Connection

Selçuk Yaylaci to Hospital Mortality

Back to Details
This is a "connection" page, showing publications Selçuk Yaylaci has written about Hospital Mortality.
Selçuk Yaylaci
Connection Strength
0.108
Hospital Mortality
  1. Impact of antihypertensive agents on clinical course and in-hospital mortality: analysis of 169 hypertensive patients hospitalized for COVID-19. Rev Assoc Med Bras (1992). 2020; 66Suppl 2(Suppl 2):71-76.
    View in: PubMed
    Score: 0.039
  2. The effect of abo and rh blood group antigens on admission to intensive care unit and mortality in patients with COVID-19 infection. Rev Assoc Med Bras (1992). 2020; 66Suppl 2(Suppl 2):86-90.
    View in: PubMed
    Score: 0.039
  3. Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study Turk J Med Sci. 2021 04 30; 51(2):440-447.
    View in: PubMed
    Score: 0.010
  4. Clinical course of COVID-19 disease in immunosuppressed renal transplant patients Turk J Med Sci. 2021 04 30; 51(2):428-434.
    View in: PubMed
    Score: 0.010
  5. Effects on mortality of early vs late administration of convalescent plasma in the treatment of Covid-19. Transfus Apher Sci. 2021 Aug; 60(4):103148.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.